Chai, Andreas C. http://orcid.org/0000-0001-8651-0164
Cui, Miao
Chemello, Francesco http://orcid.org/0000-0002-3877-527X
Li, Hui http://orcid.org/0000-0002-4114-8349
Chen, Kenian
Tan, Wei
Atmanli, Ayhan
McAnally, John R.
Zhang, Yu http://orcid.org/0000-0003-3384-8887
Xu, Lin http://orcid.org/0000-0001-5815-4457
Liu, Ning
Bassel-Duby, Rhonda http://orcid.org/0000-0001-7568-410X
Olson, Eric N. http://orcid.org/0000-0003-1151-8262
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL-130253, HL-157281, F30HL163915)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-087351)
Foundation Leducq Transatlantic Networks of Excellence in Cardiovascular Research Robert A. Welch Foundation
American Heart Association (907611)
Article History
Received: 28 June 2022
Accepted: 7 December 2022
First Online: 16 February 2023
Competing interests
: E.N.O. is a consultant for Vertex Pharmaceuticals and Tenaya Therapeutics. The other authors declare no competing interests.